Cargando…
Gene Therapy for Drug-Resistant Glioblastoma via Lipid-Polymer Hybrid Nanoparticles Combined with Focused Ultrasound
BACKGROUND: Therapy for glioblastoma (GBM) has always been very challenging, not only because of the presence of the blood-brain barrier (BBB) but also due to susceptibility to drug resistance. Recently, the clustered regularly interspaced short palindromic repeats (CRISPR)-associated protein 9 (CRI...
Autores principales: | Yang, Qiang, Zhou, Yanghao, Chen, Jin, Huang, Ning, Wang, Zhigang, Cheng, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802796/ https://www.ncbi.nlm.nih.gov/pubmed/33447034 http://dx.doi.org/10.2147/IJN.S286221 |
Ejemplares similares
-
Polymer–lipid hybrid nanoparticles as potential lipophilic anticancer drug carriers
por: Salel, Sedef, et al.
Publicado: (2023) -
Hesperidin-Loaded Lipid Polymer Hybrid Nanoparticles for Topical Delivery of Bioactive Drugs
por: Jangde, Rajendra, et al.
Publicado: (2022) -
Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid–polymer hybrid nanoparticles
por: Liu, Jia, et al.
Publicado: (2018) -
Lipid-polymer hybrid nanoparticle with cell-distinct drug release for treatment of stemness-derived resistant tumor
por: Shen, Shiyang, et al.
Publicado: (2023) -
Focused ultrasound for the treatment of glioblastoma
por: Roberts, Jill W., et al.
Publicado: (2022)